Female       Male    
  30days (x) 60days (y) 120days (z)   30days (x) 60days (y) 120days (z)  
MDA Med (Min-Max) Med (Min-Max) Med (Min-Max) P Med (Min-Max) Med (Min-Max) Med (Min-Max) p
Control (n=6) 377,0(174,0-838,0) 266,5(154,0-432,0) 233,0(174,0-425,0) 0,421 365,0(238,0-405,0) 198,0(164,0-921,0) c451,0(198,0-774,0) 0,140
1% (n=6) 286,5(231,0-365,0) 201,0(151,0-436,0) 251,0(154,0-335,0) 0,119 506,0(365,0-864,0)y,z 288,0(161,0-402,0)x 251,5(218,0-308,0)x 0,014*
2,5% (n=6) 253,0(191,0-345,0)z 196,0(154,0-275,0)z 387,0(211,0-620,0)x,y 0,013* 323,5(245,0-358,0)z 245,0(204,0-322,0) a176,0(144,0-405,0)x 0,034*
5% (n=6) 271,5(168,0-342,0)z 224,5(154,0-295,0)z 355,0(318,0-476,0)x,y 0,005* 312,0(161,0-449,0) 211,0(151,0-650,0) 256,5(174,0-369,0) 0,429
10% (n=6) 251,5(238,0-442,0) 166,0(157,0-385,0)z 298,0(204,0-402,0)y 0,038* 232,5(201,0-482,0) 221,0(204,0-302,0) 244,5(178,0-352,0) 0,931
p 0,246 0,577 0,062   0,094 0,641 0,048*  
MDA, in female genders of %2,5 group; 30th day<120th day and 60th day<120th day; in female genders of %5 group; 30th day<120th day and 60th day<120th day; in female genders of %10 group; 60th day<120th day. MDA, in male genders of 120th day; %2,5<control group, in male genders of %1 group; 30th day>60th day and 30th day>120th day; in male genders of %2,5 group; 30th day>120th day.
Table 2: Effects of three different periods and four different SDOA supplementation rates on large intestine MDA (nmol/g ) levels in rats.